Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2014 by Mayo Clinic.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
Tapimmune Inc.
Information provided by (Responsible Party):
Keith Knutson, Ph.D., Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01632332
First received: June 28, 2012
Last updated: April 8, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)